KRAS and triple-negative breast carcinoma: Moreover, we also found that ERK inhibition strongly enhanced the RA-induced expression of RAR-target genes in MDA-MB-231 cells, which are highly aggressive, triple negative breast cancer (TNBC) cells harboring an oncogenic KRAS mutation [33] (Figure 2B).